Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2006;113:414-419
doi: 10.1161/CIRCULATIONAHA.105.563403
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hong, M.-K.
Right arrow Articles by Park, S.-J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hong, M.-K.
Right arrow Articles by Park, S.-J.
Related Collections
Right arrow Catheter-based coronary interventions: stents
Right arrow Coronary imaging: angiography/ultrasound/Doppler/CC

(Circulation. 2006;113:414-419.)
© 2006 American Heart Association, Inc.


Interventional Cardiology

Late Stent Malapposition After Drug-Eluting Stent Implantation

An Intravascular Ultrasound Analysis With Long-Term Follow-Up

Myeong-Ki Hong, MD, PhD; Gary S. Mintz, MD; Cheol Whan Lee, MD, PhD; Duk-Woo Park, MD; Kyoung-Min Park, MD; Bong-Ki Lee, MD; Young-Hak Kim, MD, PhD; Jong-Min Song, MD, PhD; Ki-Hoon Han, MD; Duk-Hyun Kang, MD, PhD; Sang-Sig Cheong, MD, PhD; Jae-Kwan Song, MD, PhD; Jae-Joong Kim, MD, PhD; Seong-Wook Park, MD, PhD; Seung-Jung Park, MD, PhD

From the Department of Medicine, University of Ulsan College of Medicine, Asan Medical Center, Seoul (M.-K.H., C.W.L., D.-W.P., K.-M.P., B.-K.L., Y.-H.K., J.-M.S., K.-H.H., D.-H.K., J.-K.S., J.-J.K., S.-W.P., S.-J.P.) and GangNeung (S.-S.C.), Korea, and Cardiovascular Research Foundation (G.S.M.), New York, NY.

Correspondence to Seung-Jung Park, MD, PhD, Departments of Medicine, University of Ulsan College of Medicine, Cardiac Center, Asan Medical Center, 388-1 Poongnap-dong, Songpa-gu, Seoul, 138-736, Korea. E-mail sjpark{at}amc.seoul.kr

Received May 19, 2005; revision received October 7, 2005; accepted November 4, 2005.

Background— Late stent malapposition (LSM) after drug-eluting stent (DES) implantation has not been evaluated sufficiently in real-world practice.

Methods and Results— We evaluated the incidence, mechanisms, predictors, and long-term prognosis of LSM after DES implantation in 557 patients (705 native lesions; sirolimus-eluting stent in 538 lesions and paclitaxel-eluting stent in 167 lesions) in whom intravascular ultrasound was performed at index and 6-month follow-up. LSM occurred in 82 patients with 85 lesions (12.1% overall, 95% CI 9.7% to 14.5%, 71 lesions (13.2%) in sirolimus-eluting stents and 14 lesions [8.4%] in paclitaxel-eluting stents, P=0.12]; the incidence was 25.0% (4/16) after directional coronary atherectomy before stenting, 27.5% (14/51) in chronic total occlusion lesions, and 31.8% (7/22) after primary stenting in acute myocardial infarction (P=0.13, P<0.001, and P=0.001, respectively, versus elective stenting with conventional balloon predilation, 9.7% [60/616]). There was an increase of external elastic membrane area (from 17.1±3.6 to 21.4±4.8 mm2, P<0.001) that was greater than the increase in plaque area (from 9.3±2.5 to 10.5±2.7 mm2, P<0.001). Independent predictors of LSM were total stent length, primary stenting in acute myocardial infarction, and chronic total occlusion lesions. Except for 1 death in the non-LSM group, there were no major adverse cardiac events in either LSM or non-LSM patients during a mean 10-month follow-up after detection of LSM.

Conclusions— LSM occurs in 12% of cases after DES implantation. The predictors of LSM are total stent length, primary stenting in acute myocardial infarction, and chronic total occlusion lesions. LSM after DES implantation was not associated with any major adverse cardiac events during a subsequent 10-month (mean) follow-up.


 

CLINICAL PERSPECTIVE




This article has been cited by other articles:


Home page
CirculationHome page
A. Maehara, G. S. Mintz, A. J. Lansky, B. Witzenbichler, G. Guagliumi, B. Brodie, M. A. Kellett Jr, H. Parise, R. Mehran, and G. W. Stone
Volumetric Intravascular Ultrasound Analysis of Paclitaxel-Eluting and Bare Metal Stents in Acute Myocardial Infarction: The Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction Intravascular Ultrasound Substudy
Circulation, November 10, 2009; 120(19): 1875 - 1882.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll Cardiol IntvHome page
H. G. Bezerra, M. A. Costa, G. Guagliumi, A. M. Rollins, and D. I. Simon
Intracoronary Optical Coherence Tomography: A Comprehensive Review: Clinical and Research Applications
J. Am. Coll. Cardiol. Intv., November 1, 2009; 2(11): 1035 - 1046.
[Abstract] [Full Text] [PDF]


Home page
Circ Cardiovasc IntervHome page
A. Maehara, G. S. Mintz, and N. J. Weissman
Advances in Intravascular Imaging
Circ Cardiovasc Interv, October 1, 2009; 2(5): 482 - 490.
[Full Text] [PDF]


Home page
J Am Coll Cardiol IntvHome page
K. Waseda, A. Miyazawa, J. Ako, T. Hasegawa, I. Tsujino, R. Sakurai, P. G. Yock, Y. Honda, D. E. Kandzari, M. B. Leon, et al.
Intravascular Ultrasound Results From the ENDEAVOR IV Trial: Randomized Comparison Between Zotarolimus- and Paclitaxel-Eluting Stents in Patients With Coronary Artery Disease
J. Am. Coll. Cardiol. Intv., August 1, 2009; 2(8): 779 - 784.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
D. E. Drachman
Drug-Eluting Stents in Animals and Patients: Where Do We Stand Today?
Circulation, July 14, 2009; 120(2): 101 - 103.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
F. Alfonso, M.-J. Perez-Vizcayno, M. Ruiz, A. Suarez, M. Cazares, R. Hernandez, J. Escaned, C. Banuelos, P. Jimenez-Quevedo, and C. Macaya
Coronary aneurysms after drug-eluting stent implantation clinical, angiographic, and intravascular ultrasound findings.
J. Am. Coll. Cardiol., June 2, 2009; 53(22): 2053 - 2060.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll Cardiol IntvHome page
N. Gonzalo, P. Barlis, P. W. Serruys, H. M. Garcia-Garcia, Y. Onuma, J. Ligthart, and E. Regar
Incomplete Stent Apposition and Delayed Tissue Coverage Are More Frequent in Drug-Eluting Stents Implanted During Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction Than in Drug-Eluting Stents Implanted for Stable/Unstable Angina: Insights From Optical Coherence Tomography
J. Am. Coll. Cardiol. Intv., May 1, 2009; 2(5): 445 - 452.
[Abstract] [Full Text] [PDF]


Home page
Ther Adv Cardiovasc DisHome page
B. E. Stahli, G. G. Camici, and F. C. Tanner
Drug-eluting stent thrombosis
Therapeutic Advances in Cardiovascular Disease, February 1, 2009; 3(1): 45 - 52.
[Abstract] [PDF]


Home page
Eur Heart JHome page
Ph. G. Steg, K. A.A. Fox, K. A. Eagle, M. Furman, F. Van de Werf, G. Montalescot, S. G. Goodman, A. Avezum, W. Huang, J. M. Gore, et al.
Mortality following placement of drug-eluting and bare-metal stents for ST-segment elevation acute myocardial infarction in the Global Registry of Acute Coronary Events
Eur. Heart J., February 1, 2009; 30(3): 321 - 329.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll Cardiol IntvHome page
K. Tsujita, A. Maehara, G. S. Mintz, M. Poon, G. Maiolino, T. Sugaya, K. Igarashi, and M. Ochiai
Cross-Sectional and Longitudinal Positive Remodeling After Subintimal Drug-Eluting Stent Implantation: Multiple Late Coronary Aneurysms, Stent Fractures, and a Newly Formed Stent Gap Between Previously Overlapped Stents
J. Am. Coll. Cardiol. Intv., February 1, 2009; 2(2): 156 - 158.
[Full Text] [PDF]


Home page
Eur Heart JHome page
A. K.M. Hassan, S. C. Bergheanu, T. Stijnen, B. L. van der Hoeven, J. D. Snoep, J. W.M. Plevier, M. J. Schalij, and J. W. Jukema
Late stent malapposition risk is higher after drug-eluting stent compared with bare-metal stent implantation and associates with late stent thrombosis
Eur. Heart J., January 21, 2009; (2009) ehn553v1.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
H. Kelbaek, L. Thuesen, S. Helqvist, P. Clemmensen, L. Klovgaard, A. Kaltoft, B. Andersen, H. Thuesen, T. Engstrom, H. E. Botker, et al.
Drug-Eluting Versus Bare Metal Stents in Patients With ST-Segment-Elevation Myocardial Infarction: Eight-Month Follow-Up in the Drug Elution and Distal Protection in Acute Myocardial Infarction (DEDICATION) Trial
Circulation, September 9, 2008; 118(11): 1155 - 1162.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll Cardiol IntvHome page
B. L. van der Hoeven, S.-S. Liem, J. Dijkstra, S. C. Bergheanu, H. Putter, M. L. Antoni, D. E. Atsma, M. Bootsma, K. Zeppenfeld, J. W. Jukema, et al.
Stent Malapposition After Sirolimus-Eluting and Bare-Metal Stent Implantation in Patients with ST-Segment Elevation Myocardial Infarction: Acute and 9-Month Intravascular Ultrasound Results of the MISSION! Intervention Study
J. Am. Coll. Cardiol. Intv., April 1, 2008; 1(2): 192 - 201.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
B. K. Courtney, N. R. Munce, K. J. Anderson, A. S. Thind, G. Leung, P. E. Radau, F. S. Foster, I. A. Vitkin, R. S. Schwartz, A. J. Dick, et al.
Innovations in imaging for chronic total occlusions: a glimpse into the future of angiography's blind-spot
Eur. Heart J., March 1, 2008; 29(5): 583 - 593.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
A. Colombo and A. Latib
Late incomplete stent apposition after drug-eluting stent implantation: a true risk factor or "an innocent bystander"?
Heart, March 1, 2008; 94(3): 253 - 254.
[Full Text] [PDF]


Home page
HeartHome page
R Hoffmann, M-C Morice, J W Moses, P J Fitzgerald, L Mauri, G Breithardt, J Schofer, P W Serruys, H-P Stoll, and M B Leon
Impact of late incomplete stent apposition after sirolimus-eluting stent implantation on 4-year clinical events: intravascular ultrasound analysis from the multicentre, randomised, RAVEL, E-SIRIUS and SIRIUS trials
Heart, March 1, 2008; 94(3): 322 - 328.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
B. L. van der Hoeven, S.-S. Liem, J. W. Jukema, N. Suraphakdee, H. Putter, J. Dijkstra, D. E. Atsma, M. Bootsma, K. Zeppenfeld, P. V. Oemrawsingh, et al.
Sirolimus-eluting stents versus bare-metal stents in patients with ST-segment elevation myocardial infarction: 9-month angiographic and intravascular ultrasound results and 12-month clinical outcome results from the MISSION! Intervention Study.
J. Am. Coll. Cardiol., February 12, 2008; 51(6): 618 - 626.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
F. Alfonso, A. Suarez, M. J. Perez-Vizcayno, R. Moreno, J. Escaned, C. Banuelos, P. Jimenez, E. Bernardo, D. J. Angiolillo, R. Hernandez, et al.
Intravascular Ultrasound Findings During Episodes of Drug-Eluting Stent Thrombosis
J. Am. Coll. Cardiol., November 20, 2007; 50(21): 2095 - 2097.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
M.-K. Hong, G. S. Mintz, C. W. Lee, D.-W. Park, S.-W. Lee, Y.-H. Kim, D.-H. Kang, S.-S. Cheong, J.-K. Song, J.-J. Kim, et al.
Impact of Late Drug-Eluting Stent Malapposition on 3-Year Clinical Events
J. Am. Coll. Cardiol., October 9, 2007; 50(15): 1515 - 1516.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
G. Sianos, M. I. Papafaklis, J. Daemen, S. Vaina, C. A. van Mieghem, R. T. van Domburg, L. K. Michalis, and P. W. Serruys
Angiographic Stent Thrombosis After Routine Use of Drug-Eluting Stents in ST-Segment Elevation Myocardial Infarction: The Importance of Thrombus Burden
J. Am. Coll. Cardiol., August 14, 2007; 50(7): 573 - 583.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
S. R. Dixon, C. L. Grines, and W. W. O'Neill
The Year in Interventional Cardiology
J. Am. Coll. Cardiol., July 17, 2007; 50(3): 270 - 285.
[Full Text] [PDF]


Home page
Eur Heart JHome page
D. A. Siqueira, A. A. Abizaid, J. d. R. Costa, F. Feres, L. A. Mattos, R. Staico, A. A. Abizaid, L. F. Tanajura, A. Chaves, M. Centemero, et al.
Late incomplete apposition after drug-eluting stent implantation: incidence and potential for adverse clinical outcomes
Eur. Heart J., June 1, 2007; 28(11): 1304 - 1309.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
G. S. Mintz
What to Do About Late Incomplete Stent Apposition?
Circulation, May 8, 2007; 115(18): 2379 - 2381.
[Full Text] [PDF]


Home page
CirculationHome page
S. Cook, P. Wenaweser, M. Togni, M. Billinger, C. Morger, C. Seiler, R. Vogel, O. Hess, B. Meier, and S. Windecker
Incomplete Stent Apposition and Very Late Stent Thrombosis After Drug-Eluting Stent Implantation
Circulation, May 8, 2007; 115(18): 2426 - 2434.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
H. M.M. van Beusekom, F. Saia, J. D. Zindler, P. A. Lemos, S. L. S.-t. Hoor, M. A.H. van Leeuwen, P. J. de Feijter, P. W. Serruys, and W. J. van der Giessen
Drug-eluting stents show delayed healing: paclitaxel more pronounced than sirolimus
Eur. Heart J., April 12, 2007; (2007) ehm064v1.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
P. W. Serruys and J. Daemen
Late Stent Thrombosis: A Nuisance in Both Bare Metal and Drug-Eluting Stents
Circulation, March 20, 2007; 115(11): 1433 - 1439.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
G. S. Mintz and N. J. Weissman
Intravascular Ultrasound in the Drug-Eluting Stent Era
J. Am. Coll. Cardiol., August 1, 2006; 48(3): 421 - 429.
[Abstract] [Full Text] [PDF]